Role of fluorescence in situ hybridization in the diagnosis of urothelial cancer in asymptomatic hematuria patients
暂无分享,去创建一个
Peng Wang | F. Jin | Yao Zhang | Ke-qin Zhang | Yanfeng Li
[1] M. O'Donnell,et al. Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer. , 2004, The Journal of urology.
[2] P. Schellhammer,et al. Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. , 2002, The Journal of urology.
[3] D J O'Kane,et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. , 2000, The Journal of urology.
[4] R. Jenkins,et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. , 2000, The Journal of molecular diagnostics : JMD.
[5] D. Lamm,et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. , 2000, The Journal of urology.
[6] L. Ping. Chromosome aberration of urine exfoliated cells to diagnose bladder neoplasm by fluorescence in situ hybridization , 2009 .
[7] J. Ro,et al. Cytologic and histologic features of superficial bladder cancer. , 1992, The Urologic clinics of North America.